News

Rigel Pharmaceuticals Prepares for 2024 Financial Results Call

Rigel Pharmaceuticals Prepares for 2024 Financial Results Call

Rigel Pharmaceuticals to Announce Fourth Quarter Results

Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) has made an important announcement detailing its plans to share its financial performance for the fourth quarter and the full year of 2024. This financial disclosure is scheduled to occur after the market closes on a day soon approaching in March.

Details on the Conference Call

In conjunction with the release of these results, Rigel will host a live conference call that will commence promptly at 4:30 p.m. Eastern Time. This event offers a valuable opportunity for stakeholders and the interested public to tune into an overview and analysis of the company’s current financial health and future directions. This conference will provide comprehensive insights from senior management focused on the latest business developments.

How to Access the Live Call

To join the conference call, participants can simply dial either the domestic number at 877-407-3088 or the international number at 201-389-0927. For those preferring to engage online, the session will also be available via a live webcast accessible through the Investor Relations section of the company’s official website.

Webcast Replay Available

Following the live discussion, Rigel plans to archive the webcast, making it available for replay for a duration of 90 days. This will allow stakeholders who may not be able to attend the live event to catch up on the essential details regarding their financial results and business strategies.

Company Overview

Founded in 1996 and headquartered in South San Francisco, California, Rigel Pharmaceuticals, Inc. focuses on the discovery and development of innovative therapies to treat hematologic disorders and cancer. The company is dedicated to enhancing the quality of life for patients through advanced biopharmaceutical solutions. As part of its commitment to transparency and community engagement, Rigel encourages interested parties to visit their website for more updates on their marketed products and ongoing pipeline projects.

Contact Information

For inquiries related to investor relations, interested parties can reach Rigel Pharmaceuticals directly at 650.624.1232. Further, the investor relations team is always willing to provide information needed to keep all stakeholders informed.

Frequently Asked Questions

What will be discussed during the conference call?

The conference call will cover Rigel's fourth quarter and full year 2024 financial results and offer a business update from senior management.

How can I access the conference call?

Participants can join the call by dialing a domestic number or an international number, and the call is also accessible through a live webcast on Rigel's website.

Will the conference call be available for replay?

Yes, the conference call will be archived and available for replay on the Rigel Pharmaceuticals website for 90 days following the live event.

What is Rigel Pharmaceuticals known for?

Rigel Pharmaceuticals specializes in creating therapies aimed at improving the lives of patients suffering from hematologic disorders and cancer.

Where is Rigel Pharmaceuticals located?

Rigel Pharmaceuticals is headquartered in South San Francisco, California.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Survivors Secure $800M Settlement with NY Archdiocese

Updated Category News Views 160

Massive Settlement: A Long-Awaited Justice Here's a different kind of news that's hitting like a thunderbolt. Over 1,300 survivors of abuse have finally struck a landmark deal with the Archdiocese of New York. Not only are the numbers staggering, but the relief for these individuals is palpable. We're talking about more than $800 million on the table here. That's some...

Continue Reading
Swanson Nexus Pro Launch: Boost for Dietitians

Updated Category News Views 184

Swanson Enters the Education Arena for Nutritionists Swanson Vitamins is mixing things up again! This time, they're launching something called Swanson Vitamins Nexus Pro, aimed squarely at the registered dietitians and licensed nutritionists crowd. Starting out as the place to grab your basic vitamins, Swanson's not resting on their supplement laurels. No, siree. They've...

Continue Reading
Taiwan Fuses Ancient TCM with Modern Bio Tech in 2026

Updated Category News Views 170

The Dynamic Fusion of Heritage and Innovation When you think about it, mixing centuries-old herbal wisdom with today's cutting-edge biotech might sound like a plot twist, but that's exactly what's cooking in Taiwan. Over at SupplySide Global 2026 in Las Vegas, Taiwan's got something more than just traditional medicine to flaunt; it's showcasing an impressive fusion of...

Continue Reading
Likang's Bold Move: Cancer Immunotherapy at AD Summit

Updated Category News Views 127

Cancer Care Takes Center Stage Kicking off with a bang in Abu Dhabi, Likang Life Sciences has made a splash in the world of personalized cancer immunotherapy. The Abu Dhabi Future Health Summit 2026 served as the backdrop for this bold move, lighting up discussions with their AI-enabled innovations. Likang's showing at the Summit wasn't just another walk in the park—it...

Continue Reading
What to Expect: Your First Therapy Session Insights

Updated Category News Views 169

Starting With the Unknown: The Therapy Journey Begins Rolling into that first therapy session can feel like walking into a mystery with no clues. You're not alone if it stirs up some nerves—most folks feel the same, especially when it's your first rodeo in mental health support. That's where Cody Luke and David Spencer of Luke and Spencer Behavioral Health, based out in...

Continue Reading
Master Sommeliers and Italian Producers Clash on Wine Lists

Updated Category News Views 147

Wines Jockeying for New York’s Coveted Lists Alright, picture a stage set up in New York City like an arena. But instead of gladiators, you've got master sommeliers on one side and Italian wine producers on the other, each armed with their own arguments. They're locked in a battle over what it really takes to get a bottle imbedded on a New York City's prestigious wine...

Continue Reading
Darden Faces Class Action Over Reimbursement Failures

Updated Category News Views 147

Class Action Puts Darden Restaurants in Legal Hot Seat Darden Restaurants, Inc. is staring down the barrel of a lawsuit that's as fiery as a grill on a Saturday night rush. The legal cavalry from Blumenthal Nordrehaug Bhowmik De Blouw LLP has stormed in with a class action complaint, aiming dead center at Darden for allegedly breaching the California Labor Code. In plain...

Continue Reading
Bio-Thera's New Data: A Game Changer for NSCLC?

Updated Category News Views 239

A Fresh Look at Lung Cancer Solutions There's fresh meat on the oncology block, with Bio-Thera Solutions swinging for the fences at ESMO 2026, spotlighting promising Phase 2 clinical data for their combo treatment in first-line non-small cell lung cancer (NSCLC). If you're tuned into the biopharmaceutical sector or just keeping tabs on global health romps, this news sets...

Continue Reading
Amgen's IMDELLTRA® Shows Promise in SCLC Battle

Updated Category News Views 328

Breakthrough Results in SCLC Treatment For years, small cell lung cancer (SCLC) has been the unruly beast in the oncology world, defying treatment advances and keeping survival rates stubbornly low. This nasty foe might just have met its match, folks. Amgen (NASDAQ:AMGN) announced results from their Phase 3 DeLLphi-305 trial that show their drug IMDELLTRA®, when teamed...

Continue Reading
World Young Scientist Summit 2026 in Wenzhou Kicks Off

Updated Category News Views 139

Young Minds Meet AI Innovation Crack open the playbook, and it's clear: young brains from across the globe are gathering in Wenzhou, Zhejiang, China, to wrangle with AI and chart the course of science toward a sustainable future. The World Young Scientist Summit 2026 isn't just a parade of speeches and accolades. Nah, it's a deep dive into where innovative minds believe...

Continue Reading

Top 5 Most Recently Viewed Articles

McDermott's Historic Offshore Project in Qatar Marks New Era

Updated Category News Views 164

McDermott Awarded Pioneering Engineering Contract in Qatar HOUSTON — McDermott has been granted a significant definition engineering contract by QatarEnergy, marking a major milestone in the State of Qatar's offshore decommissioning efforts. Contract Overview and Scope As part of this contract, McDermott will establish a robust technical and commercial framework. This...

Continue Reading
Innovative Audio Solutions by Knowles and Mimi for Enhanced Listening

Updated Category News Views 271

Knowles Corporation and Mimi Join Forces for Audio Innovation Knowles Corporation (NYSE: KN), a renowned supplier of high-performance electronics, is revolutionizing the audio landscape through a partnership with Mimi Hearing Technologies, a leader in sound personalization software. This collaboration aims to enhance the audio experience for users of cutting-edge audio...

Continue Reading
Learning Lab Wichita Launches Innovative K-12 Education Hub

Updated Category News Views 250

Learning Lab Wichita Opens to Transform Education Learning Lab Wichita has officially opened its doors, kicking off a new era in K-12 education. This innovative hub serves as a collaborative space where a variety of educational models can thrive, enriching the learning experience for all students. A Memorable Grand Opening Celebration The grand opening event for Learning...

Continue Reading
QuadReal Elevates Debt Investment with £2.5 Billion Platform

Updated Category News Views 222

QuadReal Expands Its Commercial Real Estate Debt Platform QuadReal Property Group is making significant strides in the real estate market by launching a new commercial real estate debt platform. With a commitment of over £2.5 billion, QuadReal is set to enhance its lending capabilities in the UK and Europe. Building on a Solid Foundation This expansion builds upon the...

Continue Reading
Leverage Welcomes Jarett Hughes as First CEO and President

Updated Category News Views 233

Leverage Appoints Jarett Hughes as New Leader Leverage has announced the appointment of Jarett Hughes as its inaugural president and chief executive officer. This new advocacy organization aims to enhance the economic well-being and opportunities available to older Coloradans. Backed by a significant investment from the Next50 Foundation, Leverage intends to collaborate...

Continue Reading